#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15626	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2083	745.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	992	C	888	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29470	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3473	844.5	0	.	n	.	0	T695C	SNP	695	695	T	946	946	C	893	C	820	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29470	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3473	844.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	1889	1889	G	991	G	901	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29470	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3473	844.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2222	2222	C	979	C,T	881,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29470	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3473	844.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2296	2296	A	982	A	911	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29470	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3473	844.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2848	2848	C	850	C,G	787,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2080	folP	852	852	99.77	folP.l15.c4.ctg.1	1364	150.5	0	.	p	.	0	S68P	NONSYN	202	204	TCG	481	483	CCG	214;216;215	C;C;G	196;199;193	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2080	folP	852	852	99.77	folP.l15.c4.ctg.1	1364	150.5	0	.	p	.	0	A204V	NONSYN	610	612	GCA	889	891	GTA	183;182;179	G;T;A	166;161;159	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2080	folP	852	852	99.77	folP.l15.c4.ctg.1	1364	150.5	1	SNP	p	R228S	1	.	.	682	684	AGC	961	963	AGC	171;171;173	A;G;C	165;165;164	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5546	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3310	166.9	1	SNP	p	S91F	1	.	.	271	273	TTC	511	513	TTC	198;196;198	T;T;C	182;181;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5546	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3310	166.9	1	SNP	p	D95G	1	.	.	283	285	GGC	523	525	GGC	204;204;205	G;G,A;C	184;178,1;181	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5546	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3310	166.9	1	SNP	p	G95N	0	.	.	283	285	GGC	523	525	GGC	204;204;205	G;G,A;C	184;178,1;181	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1820	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1298	139.6	1	SNP	p	G45D	0	.	.	133	135	GGC	478	480	GGC	248;242;241	G;G;C	222;219;216	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	854	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	946	88.8	0	.	n	.	0	A197.	DEL	197	197	A	549	549	A	202	A	182	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5502	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	188.0	1	SNP	p	D86N	0	.	.	256	258	GAC	535	537	GAC	233;232;230	G;A;C	210;206;208	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5502	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	188.0	1	SNP	p	R87I	0	.	.	259	261	CGT	538	540	CGT	229;230;232	C;G;T	206;207;206	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5502	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	188.0	1	SNP	p	S87R	1	.	.	259	261	CGT	538	540	CGT	229;230;232	C;G;T	206;207;206	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5502	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	188.0	1	SNP	p	R87W	0	.	.	259	261	CGT	538	540	CGT	229;230;232	C;G;T	206;207;206	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5502	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2911	188.0	1	SNP	p	S88P	0	.	.	262	264	TCC	541	543	TCC	231;229;233	T;C;C	206;207;208	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4656	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2633	176.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1649	1651	GGC	247;242;238	G;G;C	220;217;209	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1242	1244	GCC	239;238;241	G;C;C	215;216;216	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1245	1247	ATG	245;245;245	A;T;G	222;222;221	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1257	1259	ACC	249;247;244	A;C;C	221;223;219	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1257	1259	ACC	249;247;244	A;C;C	221;223;219	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1758	1760	ACC	252;253;253	A;C,T;C	224;225,1;229	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1812	1814	GCG	248;248;251	G;C;G	226;226;226	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1812	1814	GCG	248;248;251	G;C;G	226;226;226	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1935	1937	GGT	177;178;178	G;G;T	161;163;158	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1944	1946	AGC	158;159;160	A;G;C,T	140;141;139,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4340	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2308	187.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1962	1964	CCG	148;152;153	C,CG;C;G,C	109,1;122;118,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6106	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3194	190.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1718	1720	CCG	255;258;260	C;C;G	224;230;228	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2458	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1748	140.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	526	526	C	162	C	140	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3130	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1684	185.1	1	SNP	p	G120K	1	.	.	358	360	AAG	683	685	AAG	259;259;262	A;A;G	241;240;240	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3130	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1684	185.1	1	SNP	p	N121D	0	.	.	361	363	AAC	686	688	AAC	263;262;262	A;A;C	242;240;240	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3130	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1684	185.1	1	SNP	p	A121N	1	.	.	361	363	AAC	686	688	AAC	263;262;262	A;A;C	242;240;240	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11366	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4824	234.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1356	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	944	142.3	1	SNP	p	V57M	1	.	.	169	171	ATG	526	528	ATG	286;287;288	A;T,C;G	260;263,1;264	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
